Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

NCT01536392 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Cervix

Interventions

DRUG: Granisetron
DRUG: Ondansetron
BEHAVIORAL: Questionnaires
BEHAVIORAL: Study Drug Diary

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]